@Graphire, I think the SOC in initially treating under 12’s is steroids but due to not responding to steroids, the prognosis is death. So to treat with ADULT SOC versus Remestemcrl-L is not ideal as steroids won’t work. Therefore it’s a death sentence.
But hey, they’re not my kids so let’s do the trial & make us some money!
im not saying that is what you are thinking or feeling but it sounds like what some of the FDA is. Doctor’s oath … do no harm!
MSB 2022 - The road to commercialisation, page-602
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.62 |
Change
0.043(2.70%) |
Mkt cap ! $1.846B | |||
| Open | High | Low | Value | Volume |
| $1.65 | $1.65 | $1.59 | $4.094M | 2.528M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 11 | 13091 | $1.62 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.62 | 129512 | 30 |
View Market Depth
| Last trade - 13.23pm 19/11/2024 (20 minute delay) ? |
| MSB (ASX) Chart |